Commercialization Concepts

Welcome

Listed below are concepts for commercializing various intellectual properties available for licensing from Saint Louis University. We are actively seeking partners and collaborators to pursue these concepts. If you're interested in further discussing these opportunities, please contact the Research Innovation Group at Saint Louis University.

Non-Life Science Concepts

1. Use patented environmental predictive technology (SLU ID 10-001, et. al.) to help operations directors at electric utility companies in the United States reduce the risks associated with critical weather-influenced decisions.
2. Use patented environmental predictive technology (SLU ID 10-001, et. al.) to help commodities traders in the United States reduce their financial risks by minimizing uncertainty regarding the potential influence of weather on commodities prices.
3. Use patent-pending methods for conducting multiple polymerase chain reaction (PCR) laboratory developed tests (LDTs) simultaneously on a single PCR machine (SLU ID 18-006) to help clinical laboratory directors reduce inefficiencies and costs associated with performing PCR-LDTs to diagnose diseases.
4. Use patent-pending mask-free production methods (SLU ID 16-018) to help nanomaterial product designers precisely grow dissimilar MX2 materials layered either vertically or laterally to facilitate easy incorporation into complex device architectures.
5. Use patent-pending dibenzothiophene molecules (SLU ID 16-025) to help research scientists at organic light-emitting diode (OLED) materials manufacturers develop display materials that produce longer-lasting, higher efficiency blue emitters for OLED displays.

Life Science Concepts

1. Use patented compounds and methods that employ BH3 mimetic therapy (SLU ID 06-047) to help drug developers at pharmaceutical companies develop therapeutics to treat immune system mediated disorders.
2. Use a patent-pending approach that exploits the bi-directional regulatory loop between osteoclasts and FoxP3+ CD8 T-cells (SLU ID 12-013) to help drug developers at pharmaceutical companies develop therapeutics to suppress bone loss and inflammation in individuals suffering from a variety of diseases.
3. Use patent-pending selective biomarkers identified by SLU researchers (SLU ID 14-017) to help gynecologists diagnose endometriosis-related infertility.
4. Use a patent-pending protocol involving an agent that suppresses or blocks S1P or S1P receptor biological activity (SLU ID 14-017) to help gynecologists treat endometriosis-related infertility.
5. Use a patented method for suturelessly implanting a sponge beneath the surface of the sclera (SLU ID 07-023) to enable ophthalmologists deliver medication to the eye to treat diseases.
6. Use patent-pending biomimetic sponge material (SLU ID 17-025) to help physicians treat bulk tissue and muscle loss.
7. Use patented diagnostic methods (SLU ID 07-017) to help physicians characterize a patient's risk for having an adverse coronary event and to help individuals assess their need to more closely monitor their heart health.

To view a complete list of technologies available for licensing from Saint Louis University, please visit the Research Innovation Group home page.